𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating gangliosides of breast-cancer patients

✍ Scribed by Douglas A. Wiesner; Charles C. Sweeley

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
880 KB
Volume
60
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Gangliosides were isolated from the sera of recently diagnosed breast-cancer patients and from individuals who were apparently free of disease. Quantificative and qualitative analyses were carried out by 2-dimensional high-performance thinlayer chromatography and gas chromatography. The locations of isolated gangliosides on thin-layer chromatograms were determined by visualization with resorcinol, and each spot was quantified by digital image densitometry. The ganglioside profiles of cancer patients were compared to those of the control group, revealing a significant increase in total lipid-bound sialic acid and a specific increase in polysialogangliosides in the patients with breast cancer. Furthermore, an increase was noted in the ratio of gangliosides of the b-series biosynthetic pathway over those of the a-series in the cancer sera, as compared to the controls. Gas chromatographic analysis of the peracetylated methanolysis mixtures derived from the total ganglioside fraction of cancer patients supported the HPTLC data, with an increase in total sialic acid, galactose, and sphingosine residues. No unusual gangliosides were found in the mixture from breast-cancer patients.

πŸ“œ SIMILAR VOLUMES

Characterization of metastatic breast ca
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
✍ Michal Mego; Ugo De Giorgi; Shahenaah Dawood; Xuemei Wang; Vicente Valero; Eleni πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 159 KB πŸ‘ 1 views

## Abstract Circulating tumor cells (CTC) are an independent prognostic factor in metastatic breast cancer patients (MBC). However, CTC are undetectable in one third of patients. The aim of this study was to assess the prognostic factors in MBC patients without detectable CTC. This retrospective st

Clinical significance of circulating imm
Clinical significance of circulating immune complexes in patients with metastatic breast cancer
✍ G. Krieger; A. Kehl; H.-E. Wander; A.-M. Salo; H. F. Rauschecker; G. A. Nagel πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 French βš– 541 KB

## Abstract Serum circulating immune complexes (CIC) were repeatedly measured by means of the Cl binding assay (Cba) and the Raji cell assay (Rca) in 158 patients with metastatic breast cancer (mbc). Frequency of occurrence and levels of CIC were only slightly increased in mbc when compared to age‐

A prospective study of circulating immun
A prospective study of circulating immune complexes in patients with breast cancer
✍ A. Bukh; M. T. Aguado; N. Krarup; H. S. Poulsen; A. M. Nordentoft; N. P. H. Moll πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 795 KB

Levels of circulating immune complex (clC) and complement split product C3d were studied in 86 patients with breast cancer (BC), 22 patients with benign breast disease (BD), and 72 age-and sex-matched blood-bank donors (NC), using solidphase Clq-protein A RIA, C I q-anti-lgG RIA, anti-C3d anti-lgG R

Circulating interleukin-6 predicts survi
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra

Immunogenicity of melanoma-associated ga
Immunogenicity of melanoma-associated gangliosides in cancer patients
✍ Tadashi Tai; Leslie D. Cahan; Tetsuya Tsuchida; Romaine E. Saxton; Reiko F. Irie πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 French βš– 826 KB

## Abstract The immunogenicity of gangliosides found on human melanoma cells was determined from sera of 26 melanoma patients who were immunized every 1–4 weeks for 4 months with tumor‐cell vaccine (TCV) prepared from cultured melanoma cells. Total lipidbound sialic acid in the gangliosides isolate